United Therapeutics | UTHR - Ebit


United Therapeutics reported $-14.6M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Amarin USD -1.7M 8.47M Sep/2025
Ardelyx USD 7.12M 19.62M Sep/2025
Baxter International USD -214.2M 415.4M Dec/2025
Bayer EUR 1.11B 1.51B Dec/2025
BioCryst Pharmaceuticals USD 260.38M 230.79M Dec/2025
Biogen USD 659.6M 157M Sep/2025
BioMarin Pharmaceutical USD 198.39M 230.08M Dec/2025
Esperion Therapeutics USD 85.23M 95.19M Dec/2025
Gilead Sciences USD 2.96B 551M Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
Halozyme Therapeutics USD -88.41M 306.33M Dec/2025
Insmed USD -249.71M 11.64M Dec/2025
Ionis Pharmaceuticals USD -215M 54.82M Dec/2025
J&J USD 5.11B 2.3B Dec/2025
Lexicon Pharmaceuticals USD -14.78M 2.59M Dec/2025
Moderna USD -857M 597M Dec/2025
Omeros USD -48.15M 7.25M Sep/2023
Pfizer USD 4.65B 71M Dec/2025
PTC Therapeutics USD -81.62M 85.11M Dec/2025
Regeneron Pharmaceuticals USD 898.6M 211.3M Dec/2025
Sarepta Therapeutics USD -410.08M 347.2M Dec/2025
Teva Pharmaceutical Industries USD 577M 491M Dec/2025
United Therapeutics USD -14.6M 403.9M Dec/2025
Vertex Pharmaceuticals USD 1.26B 24.5M Dec/2025